ELECTRON-SPIN-RESONANCE ANALYSIS OF HEME-NITROSYL AND REDUCED IRON-SULFUR CENTERED COMPLEXES IN ALLOGENEIC, HETEROTOPIC CARDIAC TRANSPLANTS- EFFECTS OF TREATMENT WITH PYRROLIDINE DITHIOCARBAMATE
Al. Nakanishi et al., ELECTRON-SPIN-RESONANCE ANALYSIS OF HEME-NITROSYL AND REDUCED IRON-SULFUR CENTERED COMPLEXES IN ALLOGENEIC, HETEROTOPIC CARDIAC TRANSPLANTS- EFFECTS OF TREATMENT WITH PYRROLIDINE DITHIOCARBAMATE, Free radical biology & medicine, 25(2), 1998, pp. 201-207
Inhibition of inducible nitric oxide synthase (iNOS) prolongs allograf
t survival suggesting a role for nitric oxide ((NO)-N-.) in allograft
rejection. Induction of iNOS is regulated by the oxidant-sensitive, nu
clear factor kappa B (NF-KB) in many cell types. In the present study
using electron spin resonance (ESR) spectroscopy, we evaluated whether
pyrrolidine dithiocarbamate (PDTC), a metal chelator and antioxidant,
might limit (NO)-N-. production during the development of rejection i
n cardiac allografts. We performed either isogeneic (Lewis to Lewis) o
r allogeneic (Wistar-Furth to Lewis) heterotopic abdominal cardiac tra
nsplantation. Allograft recipients received daily injections of PDTC o
r aminoguanidine (a known inhibitor of iNOS). At postoperative days 4,
or 6, grafted and native hearts of transplant recipients were flushed
with cardioplegic solution to remove blood contamination. ESR data of
allografts revealed a triplet nitrogen signal (a(N) = 17.5 G) and cen
tered at g = 2.012 and an additional broad signal at g = 2.08. This si
gnal was not seen in either isografts or native hearts of either isogr
aft or allograft recipients. Based upon these parameters, these signal
s are attributed to nitrosomyoglobin. This signal was inhibited by tre
atment with aminoguanidine or PDTC. Under these conditions, PDTC also
prolonged graft survival from 6.6 +/- 0.2 to 11.7 +/- 0.3 days. Thus,
it is conceivable that nitrosylmyoglobin formation precedes rejection
in cardiac allografts and inhibition of nitrosomyoglobin with agents s
uch as PDTC contribute to improved graft survival. (C) 1998 Elsevier S
cience Inc.